SBS-1000
/ Sparian Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 27, 2025
A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=48 | Completed | Sponsor: Sparian Biosciences, Inc | Recruiting ➔ Completed
Trial completion • Pain
February 10, 2023
A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=56 | Recruiting | Sponsor: Sparian Biosciences, Inc
New P1 trial • Pain
1 to 2
Of
2
Go to page
1